Bio & Insurance Information

Dr. Rahul Aggarwal graduated from the Northwestern University Feinberg School of Medicine. He did both his residency in internal medicine and his fellowship in hematology/oncology at the UCSF. He is board certified in the field of hematology, internal medicine, and medical oncology. As a medical oncologist, he is specialized in the treatment of cancer affecting the lungs, larynx, and ovary as well as mesothelioma. With around a decade of clinical experience, he is currently affiliated with the UCSF Medical Center. Dr. Aggarwal has also contributed to six research papers.



Education & Training

Northwestern University Feinberg

Medical School

UCSF

Residency

UCSF

Fellowship

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Hematology

American Board of Internal Medicine - Oncology

Hospitals & Clinics

UCSF Medical Center

Languages: English/Spanish

(415) 353-1037

505 Parnassus Ave

San Francisco, California 94143

Read More

Publications

Dr. Rahul Aggarwal has contributed to 3 publications.

A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.

Thomas, S.,Aggarwal, R.,Jahan, T.,Ryan, C.,Troung, T.,Moore Cripps, A.,Raha, P.,Thurn, K. T.,Chen, S.,Grabowsky, J. A.,Park, J.,Hwang, J.,Daud, A.,Munster, P. N.; Ann. Oncol.. 2016 Feb 24.

See more >>

First-in-human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-kinase inhibitor, in Patients with Advanced Solid Tumor Malignancies.

Munster, P. N.,Aggarwal, R.,Hong, D.,Schellens, J. H.,van der Noll, R.,Specht, J.,Witteveen, P. O.,Werner, T.,Dees, E. C.,Bergsland, E. K.,Agarwal, N.,Kleha, J. F.,Dur...; Clin. Cancer Res.. 2015 Nov 26.

See more >>

Somatostatin Imaging of Neuroendocrine-Differentiated Prostate Cancer.

Hope, T. A.,Aggarwal, R.,Simko, J. P.,VanBrocklin, H. F.,Ryan, C. J.; Clin Nucl Med. 2015 Mar 19.

See more >>